文献速递妇科

黏液性卵巢癌免疫微环境特征分析

Profiling the immune landscape in mucinous ovarian carcinoma.
PubMed 文献 · Gynecol Oncol · 2022-11-08

该研究对126例黏液性卵巢癌(MOC)患者组织芯片进行多重免疫组化和免疫荧光检测,分析免疫细胞密度与临床因素及总生存的关系。结果显示86%的MOC为免疫耗竭(冷)表型,仅14%(11/76)为免疫炎症(热)表型,提示MOC对当前免疫治疗可能反应有限。

要点

  • 多数MOC(86%)为免疫耗竭(冷)表型,仅14%(11/76)为免疫炎症(热)表型。
  • 晚期(III/IV期)MOC上皮内PD-L1-巨噬细胞浸润多于I/II期,而PD-L1+巨噬细胞少于I/II期(p=0.004和p=0.014)。
  • 上皮高密度FOXP3+细胞、CD8+/FOXP3+细胞或PD-L1-巨噬细胞与更差生存相关,仅单因素分析。

核心结论

  • MOC大多为免疫原性「冷」肿瘤,提示对当前免疫治疗可能反应有限。

研究设计与样本

  • 对126例MOC患者的组织芯片进行多重免疫组化和免疫荧光检测,计算上皮和间质中多种免疫细胞密度,并与临床因素比较,采用单因素和多因素Cox比例风险模型评估总生存,无监督k均值聚类识别免疫细胞浸润模式。

主要发现

  • PD1+细胞、PD-L1-巨噬细胞、CD4+和CD8+T细胞及FOXP3+Tregs的平均密度在间质中高于上皮。
  • 晚期(III/IV期)MOC上皮内PD-L1-巨噬细胞浸润多于I/II期,而PD-L1+巨噬细胞少于I/II期(p=0.004和p=0.014)。
  • 单因素分析中,上皮高密度FOXP3+细胞、CD8+/FOXP3+细胞或PD-L1-巨噬细胞与更差生存相关,上皮高密度CD79a+浆细胞与更好生存相关。
  • 聚类分析显示86%的MOC为免疫耗竭(冷)表型,仅14%(11/76)为免疫炎症(热)表型。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Mucinous ovarian carcinoma (MOC) is a rare histotype of ovarian cancer, with low response rates to standard chemotherapy, and very poor survival for patients diagnosed at advanced stage. There is a limited understanding of the MOC immune landscape, and consequently whether immune checkpoint inhibitors could be considered for a subset of patients. METHODS: We performed multicolor immunohistochemistry (IHC) and immunofluorescence (IF) on tissue microarrays in a cohort of 126 MOC patients. Cell densities were calculated in the epithelial and stromal components for tumor-associated macrophages (CD68+/PD-L1+, CD68+/PD-L1-), T cells (CD3+/CD8-, CD3+/CD8+), putative T-regulatory cells (Tregs, FOXP3+), B cells (CD20+/CD79A+), plasma cells (CD20-/CD79a+), and PD-L1+ and PD-1+ cells, and compared these values with clinical factors. Univariate and multivariable Cox Proportional Hazards assessed overall survival. Unsupervised k-means clustering identified patient subsets with common patterns of immune cell infiltration. RESULTS: Mean densities of PD1+ cells, PD-L1- macrophages, CD4+ and CD8+ T cells, and FOXP3+ Tregs were higher in the stroma compared to the epithelium. Tumors from advanced (Stage III/IV) MOC had greater epithelial infiltration of PD-L1- macrophages, and fewer PD-L1+ macrophages compared with Stage I/II cancers (p = 0.004 and p = 0.014 respectively). Patients with high epithelial density of FOXP3+ cells, CD8+/FOXP3+ cells, or PD-L1- macrophages, had poorer survival, and high epithelial CD79a + plasma cells conferred better survival, all upon univariate analysis only. Clustering showed that most MOC (86%) had an immune depleted (cold) phenotype, with only a small proportion (11/76,14%) considered immune inflamed (hot) based on T cell and PD-L1 infiltrates. CONCLUSION: In summary, MOCs are mostly immunogenically 'cold', suggesting they may have limited response to current immunotherapies.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Meagher NS, Hamilton P, Milne K, et al. Profiling the immune landscape in mucinous ovarian carcinoma. Gynecol Oncol. 2022. PMID: 36368129. doi:10.1016/j.ygyno.2022.10.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。